Wenying Pan

Wenying Pan serves as the Chief Scientific Officer at GeneGenieDx Corp since February 2020. Prior to this role, Wenying Pan was a Bioinformatic Scientist at GRAIL, Inc. from August 2016 to February 2020, focusing on next-generation sequencing data analysis for early cancer screening. Wenying Pan's experience includes a position as a Graduate Research Assistant at Stanford University from September 2010 to June 2016, where contributions included developing a sequencing method for prenatal diagnosis through a longitudinal study on cell-free RNA. Additionally, Wenying Pan worked as a Research Scientist at the National Center for Nanoscience and Technology from July 2008 to June 2010, developing a microfluidic biochip for multiplex western blotting. Wenying Pan holds a PhD in Bioengineering from Stanford University and a BS in Chemistry from Tsinghua University.